AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 49 filers reported holding AUTOLUS THERAPEUTICS PLC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $122,062 | -2.1% | 52,387 | 0.0% | 0.00% | – |
Q2 2023 | $124,681 | -31.5% | 52,387 | -48.3% | 0.00% | – |
Q1 2023 | $181,982 | -10.6% | 101,247 | -5.5% | 0.00% | – |
Q4 2022 | $203,516 | +78.5% | 107,114 | +100.9% | 0.00% | – |
Q3 2022 | $114,000 | -25.5% | 53,317 | -1.1% | 0.00% | – |
Q2 2022 | $153,000 | -49.0% | 53,927 | -25.0% | 0.00% | – |
Q1 2022 | $300,000 | -62.1% | 71,900 | -52.8% | 0.00% | – |
Q4 2021 | $791,000 | +143.4% | 152,372 | +207.4% | 0.00% | – |
Q3 2021 | $325,000 | +122.6% | 49,566 | +125.1% | 0.00% | – |
Q2 2021 | $146,000 | +13.2% | 22,019 | -2.3% | 0.00% | – |
Q1 2021 | $129,000 | -35.8% | 22,534 | 0.0% | 0.00% | – |
Q4 2020 | $201,000 | -28.7% | 22,534 | -7.1% | 0.00% | – |
Q3 2020 | $282,000 | +55.8% | 24,267 | +115.4% | 0.00% | – |
Q2 2020 | $181,000 | +154.9% | 11,268 | -4.9% | 0.00% | – |
Q1 2020 | $71,000 | -57.7% | 11,844 | -6.8% | 0.00% | – |
Q4 2019 | $168,000 | +5.0% | 12,708 | -1.5% | 0.00% | – |
Q3 2019 | $160,000 | – | 12,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FRAZIER MANAGEMENT LLC | 3,530,657 | $23,126,000 | 1.85% |
TFG Asset Management GP Ltd | 2,500,000 | $16,375,000 | 1.00% |
Nantahala Capital Management | 2,936,791 | $19,236,000 | 0.61% |
MYDA Advisors LLC | 171,953 | $1,126,000 | 0.32% |
SABBY MANAGEMENT, LLC | 300,000 | $1,965,000 | 0.27% |
Regency Capital Management Inc.\DE | 57,000 | $373,000 | 0.26% |
Ikarian Capital, LLC | 544,819 | $3,568,000 | 0.25% |
Eversept Partners, LP | 398,074 | $2,607,385 | 0.18% |
Henry James International Management Inc. | 54,047 | $354,000 | 0.11% |
Alphabet Inc. | 698,262 | $4,574,000 | 0.11% |